Zobrazeno 1 - 10
of 162
pro vyhledávání: '"Howard D Homesley"'
Autor:
Barbara M. Norquist, Danielle Enserro, Bradley J. Monk, Michael A. Bookman, Matthew P. Boente, John K. Chan, Robert L. Coleman, Robert A. Burger, Michael J. Birrer, Philip J. DiSaia, Thomas J. Herzog, Krishnansu S. Tewari, Benjamin E. Greer, Helen Q. Huang, Howard D. Homesley, Elizabeth M. Swisher, Carlos Bais, Mark F. Brady, Leslie M. Randall, C. Ye, Larry J. Copeland, Sharon X. Liang, J. Stuart Ferriss, Carol Aghajanian, Robert S. Mannel, Gini F. Fleming, Jeffrey M. Fowler
Publikováno v:
J Clin Oncol
PURPOSE We report the final, protocol-specified analysis of overall survival (OS) in GOG-0218, a phase III, randomized trial of bevacizumab in women with newly diagnosed ovarian, fallopian tube, or primary peritoneal carcinoma. METHODS A total of 1,8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca405a5ed9df8156bdd64185764ea1e
https://doi.org/10.1200/jco.19.01009
https://doi.org/10.1200/jco.19.01009
Autor:
Danielle Enserro, David Miller, Koen DeGeest, Susan K. Gibbons, David Cella, Howard D. Homesley, Robert T. Morris, Nick M. Spirtos, Roger B. Lee
Publikováno v:
Gynecol Oncol
Objectives To determine if the addition of paclitaxel (P) to cisplatin and doxorubicin (CD) following surgical debulking and volume-directed radiation therapy improved long-term, recurrence-free survival (RFS) and overall survival (OS) in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcd48a70680fa590b41e4ea067a19cd4
https://pubmed.ncbi.nlm.nih.gov/31053405
https://pubmed.ncbi.nlm.nih.gov/31053405
Autor:
Sharon X. Liang, Noriyuki Katsumata, Joan L. Walker, Matthew P. Boente, Michael A. Bookman, Howard D. Homesley, Bradley J. Monk, Gini F. Fleming, Stephen C. Rubin, Benjamin E. Greer, Robert A. Burger, Jeffrey M. Fowler, Mark F. Brady, Peter Lim
Publikováno v:
Journal of Clinical Oncology. 32:1210-1217
Purpose To evaluate risk factors for GI adverse events (AEs) within a phase III trial of bevacizumab in first-line ovarian cancer therapy. Patients and Methods Women with previously untreated advanced disease after surgery were randomly allocated to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f655fd9d3a7c1e80a6f50b32dc31147f
https://doi.org/10.1200/jco.2013.53.6524
https://doi.org/10.1200/jco.2013.53.6524
Autor:
Howard D. Homesley, Toshiaki Nakamura, Linda Van Le, Peter G. Rose, J. Tate Thigpen, Elizabeth R. Burton, Jacob Rotmensch, Joshua Kesterson, Mark F. Brady
To estimate the probability of complete clinical response and toxicity of paclitaxel as second-line chemotherapy in measurable disease patients with malignant tumors of the ovarian stroma, and to evaluate the value of inhibin for predicting response.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57fd45cb2e50ffb873da2ee6544a1743
Autor:
Allan Hallquist, Carl Rogaston Willis, Michael R. Chernick, Linda D. Bosserman, Franklyn G Prendergast, James Rutledge, Mathieu Perree, Howard D. Homesley, Martin Fleisher, Dirk C. Davidson, Matthew Burrell, Roy S. Herbst, Audrey Garrett, Manuel Penalver, Swapnil Rajurkar, Misagh Karimi, Steven Strickland, Emery M. Salom, Karl Rogers, Cary A. Presant, Anastasios Raptis
Publikováno v:
Cancer Research. 72:3901-3905
A drug-induced apoptosis assay, termed the microculture-kinetic (MiCK) assay, has been developed. Blinded clinical trials have shown higher response rates and longer survival in groups of patients with acute myelocytic leukemia and epithelial ovarian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c83d4df2d6d01f0b83cd128ca31c2fc5
https://doi.org/10.1158/0008-5472.can-12-0681
https://doi.org/10.1158/0008-5472.can-12-0681
Autor:
Helen Michael, Wui Jin Koh, Shamshad Ali, Joan L. Walker, Howard D. Homesley, David H. Moore, Mack N. Barnes, Carolyn K. McCourt
Publikováno v:
Gynecologic Oncology. 124:529-533
Objectives To determine the efficacy and toxicity of radiation therapy and concurrent weekly cisplatin chemotherapy in achieving a complete clinical and pathologic response when used for the primary treatment of locally-advanced vulvar carcinoma. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd7ee66a2bac5a4970e347280647db65
https://doi.org/10.1016/j.ygyno.2011.11.003
https://doi.org/10.1016/j.ygyno.2011.11.003
Autor:
Jeffrey F. Hines, Peter Lim, Luping Zhao, John F. Gill, Scott McMeekin, Howard D. Homesley, Alan N. Gordon, Michael Teneriello, M. Dwight Chen, Coleman K. Obasaju, Yanping Wang, Luis Vaccarello, Mike F. Janicek, Mauro Orlando, Datchen Fritz Tai, Tiana L. Burkholder
Publikováno v:
Gynecologic Oncology. 123:479-485
Objective The safety and efficacy of gemcitabine plus carboplatin (GC) or paclitaxel plus carboplatin (TC) induction regimens with or without paclitaxel consolidation therapy were assessed in ovarian cancer (OC). Methods Patients with stage IC–IV O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::169b7b141de065d62d818e1f4a5d71df
https://doi.org/10.1016/j.ygyno.2011.08.018
https://doi.org/10.1016/j.ygyno.2011.08.018
Autor:
Howard D. Homesley, Nick M. Spirtos, David Cella, Helen Q. Huang, Roger B. Lee, Anthony G. Montag, Koen De Geest, Ritu Salani
Publikováno v:
Gynecologic Oncology. 119:538-542
In GOG 184, the addition of paclitaxel to cisplatin and doxorubicin offered no additional clinical benefit, yet was associated with increased provider-rated toxicity. We now compare patient-reported neuropathy between treatment arms and patient repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0803a3f7938edc1b4219b0b4564fd243
https://doi.org/10.1016/j.ygyno.2010.08.022
https://doi.org/10.1016/j.ygyno.2010.08.022
Autor:
F B S Mark Brady, Robert C. Young, Hervy E. Averette, Leslie A. Walton, Howard D. Homesley, Harry J. Long
Publikováno v:
Cancer. 71:601-605
The appropriate therapy for patients with localized (FIGO Stage I and II) ovarian cancer has been poorly defined for all age groups and particularly for the elderly. Few prospective randomized comparisons of adjuvant therapy after careful surgical st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a313002fe4bac25f3bb8734613040988
https://doi.org/10.1002/cncr.2820710217
https://doi.org/10.1002/cncr.2820710217
Autor:
Koen DeGeest, Harry J. Long, Nick M. Spirtos, Anthony G. Montag, David Cella, Howard D. Homesley, Robert T. Morris, Virginia L. Filiaci, Roger B. Lee, Susan K. Gibbons
Publikováno v:
Gynecologic Oncology. 112:543-552
After surgical debulking and volume-directed irradiation of the pelvis/para-aortic lymph nodes, treatment was randomized to compare recurrence-free survival (RFS) and toxicity between two chemotherapy regimens for the treatment of women with advanced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b9f90c08b49f524bb5324b4d97fa56c
https://doi.org/10.1016/j.ygyno.2008.11.014
https://doi.org/10.1016/j.ygyno.2008.11.014